AZN

AstraZeneca PLC (AZN)

Last Price$63.2(2.8%)
Market Cap$270.4B
LTM Revenue
$51.2B
YoY Growth
+13.8%
3Y CAGR
+16.0%
5Y CAGR
+16.2%
Stock quality & Intrinsic value
6/10
23.6% undervalued

AstraZeneca PLC Revenue

Annual
Quarterly
LTM
Crunching data... Almost there!
Dec'04Dec'05Dec'06Dec'07Dec'08Dec'09Dec'10Dec'11Dec'12Dec'13Dec'14Dec'15Dec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23
Revenue
$21.4B
$24.0B
$26.5B
$29.6B
$31.6B
$32.8B
$33.3B
$33.6B
$28.0B
$25.7B
$26.1B
$24.7B
$23.0B
$22.5B
$22.1B
$24.4B
$26.6B
$37.4B
$44.4B
$45.8B
See the AZN
full fundamental analysis
View -->
Overvalued or undervalued?
Check the intrinsic value for AZN
Explore -->

AstraZeneca PLC (AZN) Revenue comparison analysis

Crunching data... Almost there!

Discover more Stock Ideas

Loved by
investors
worldwide
10K+
Investors use our platform
#1
Top value investing hub with all necessary tools
1K+
Experienced investors in our community
4.9
Average rating across all rating platforms

FAQ

1) What is AstraZeneca PLC's Revenue?

As of today, AstraZeneca PLC's last 12-month Revenue is $51.2B, based on the financial report for Sep 30, 2024 (Q3 2024).

2) What is AstraZeneca PLC's Revenue growth rate?

Over the last year, AstraZeneca PLC's Revenue growth was 13.8%. The average annual Revenue growth rates for AstraZeneca PLC have been 22.9% over the past three years, 16.2% over the past five years.

3) Is AstraZeneca PLC's Revenue growth rate Good?

Over the last year, AstraZeneca PLC's Revenue growth was 13.8%, which is higher than industry growth of 0.1%. It indicates that AstraZeneca PLC's Revenue growth is Good.

4) How does AstraZeneca PLC's Revenue growth rate compare to its peers?

Over the last year, AstraZeneca PLC's Revenue growth was 13.8%, which is higher than peer median growth of 3.7%. The list of peers includes JNJ, SNY, MRK, PFE, ABBV, NVS, BMY, LLY, AMGN, GILD etc.